Effect of Extracellular ATP on Cisplatin-Induced Cytotoxicity in Human Ovarian Carcinoma Cells

被引:8
作者
Rotte, Anand [1 ]
Garmann, Dirk [1 ]
Buss, Irina [1 ]
Jaehde, Ulrich [1 ]
机构
[1] Univ Bonn, Dept Clin Pharm, Inst Pharm, DE-53121 Bonn, Germany
关键词
ATP; Cancer; Cisplatin; Cytotoxicity; COPPER TRANSPORTER CTR1; GROWTH-INHIBITION; LEUKEMIA-CELLS; CANCER-CELLS; ADENOSINE-TRIPHOSPHATE; PASSIVE PERMEABILITY; EXTERNAL ATP; TUMOR-CELLS; RESISTANCE; INVOLVEMENT;
D O I
10.1159/000287351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cisplatin resistance has been mainly associated with decreased cellular accumulation and increased intracellular glutathione (GSH) levels. ATP is known to increase the membrane permeability of cells and to decrease intracellular GSH levels. Our study aimed at using extracellular ATP to sensitize ovarian carcinoma cells towards cisplatin. Methods: The MTT assay was used to determine the EC50 of cisplatin in the human ovarian carcinoma cell line A2780 and its cisplatin-resistant variant A2780cis. Intracellular platinum concentrations were determined using flameless atomic absorption spectrometry. Results: Preincubation and concomitant incubation with ATP did not alter the EC50 of cisplatin. The presence of 100 mu M ATP along with cisplatin decreased cell survival in A2780 but not in A2780cis cells. Extracellular ATP did not increase the cellular accumulation of cisplatin in both A2780 and A2780cis cells. Conclusion: The presence of extracellular ATP during treatment with cisplatin leads to additive cytotoxicity in the sensitive A2780 but not in cisplatin-resistant A2780cis cells. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:1 / 8
页数:8
相关论文
共 41 条
  • [1] Altaha R, 2004, INT J MOL MED, V14, P959
  • [2] BEHRENS BC, 1987, CANCER RES, V47, P414
  • [3] Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients
    Beijer, Sandra
    Gielisse, Eric A. R.
    Hupperets, Pierre S.
    van den Borne, Ben E. E. M.
    van den Beuken-van Everdingen, Marieke
    Nijziel, Marten R.
    van Henten, Arjen M. J.
    Dagnelie, Pieter C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (06) : 571 - 579
  • [4] Extracellular ATP increases [CA2+]i in distal tubule cells.: I.: Evidence for a P2Y2 purinoceptor
    Bidet, M
    De Renzis, G
    Martial, S
    Rubera, I
    Tauc, M
    Poujeol, P
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (01) : F92 - F101
  • [5] KINETICS AND MECHANISM OF UPTAKE OF PLATINUM-BASED PHARMACEUTICALS BY THE RAT SMALL-INTESTINE
    BINKS, SP
    DOBROTA, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (06) : 1329 - 1336
  • [6] Modification and uptake of a cisplatin carbonato complex by Jurkat cells
    Centerwall, Corey R.
    Tacka, Kirk A.
    Kerwood, Deborah J.
    Goodisman, Jerry
    Toms, Bonnie B.
    Dubowy, Ronald L.
    Dabrowiak, James C.
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (01) : 348 - 355
  • [7] Extracellular ATP-Dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms
    Conigrave, AD
    van der Weyden, L
    Holt, L
    Jiang, L
    Wilson, P
    Christopherson, RI
    Morris, MB
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (11) : 1585 - 1591
  • [8] Extracellular ATP and cancer - An overview with special reference to P2 purinergic receptors
    Deli, Tamas
    Csernoch, Laszlo
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (03) : 219 - 231
  • [9] ELIMINATION OF EHRLICH TUMORS BY ATP-INDUCED GROWTH-INHIBITION, GLUTATHIONE DEPLETION AND X-RAYS
    ESTRELA, JM
    OBRADOR, E
    NAVARRO, J
    DELAVEGA, MCL
    PELLICER, JA
    [J]. NATURE MEDICINE, 1995, 1 (01) : 84 - 88
  • [10] CELLULAR ACCUMULATION OF THE ANTICANCER AGENT CISPLATIN - A REVIEW
    GATELY, DP
    HOWELL, SB
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (06) : 1171 - 1176